Locations
South San Francisco, CA, USA · Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2022
Vilya is a cutting-edge computational biotechnology company, co-founded by a team of scientists from the Institute of Protein Design (IPD) led by David Baker, Ph.D., and by Arch Venture Partners. At Vilya, we are creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space within cyclic peptides to design new molecular structures not found in nature. We aim to boldly leverage cutting-edge computing to change how we design new medicines and to ultimately cure diseases. Who will love working with us? We are a group of machine learning scientists, computational chemists, medicinal chemists, biologists, and scientific enthusiasts that are driven to design and create life-altering medicines that will make a big impact on the world. Learn more about our job openings and join us!
Something looks off?